Authors: Turton, NJ Judah, DJ Riley, J Davies, R Lipson, D Styles, JA Smith, AG Gant, TW

Citation: Nj. Turton et al., Gene expression and amplification in breast carcinoma cells with intrinsicand acquired doxorubicin resistance, ONCOGENE, 20(11), 2001, pp. 1300-1306

Authors: Gill, PK Gescher, A Gant, TW

Citation: Pk. Gill et al., Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta, EUR J BIOCH, 268(15), 2001, pp. 4151-4157

Authors: Riley, J Styles, J Verschoyle, RD Stanley, LA White, INH Gant, TW

Citation: J. Riley et al., Association of tamoxifen biliary excretion rate with prior tamoxifen exposure and increased mdr1b expression, BIOCH PHARM, 60(2), 2000, pp. 233-239

Authors: Davies, R Gant, TW Lewis, LL Styles, JA

Citation: R. Davies et al., Tamoxifen induces G : C -> T : A mutations in the cII gene in the liver oflambda/lacI transgenic rats but not at 5 '-CpG-3 ' dinucleotide sequences as found in the lacI transgene, CARCINOGENE, 20(7), 1999, pp. 1351-1356

Authors: Lowes, DA Brown, K Heydon, RT Martin, EA Gant, TW

Citation: Da. Lowes et al., Site-specific tamoxifen-DNA adduct formation: Lack of correlation with mutational ability in Escherichia coli, BIOCHEM, 38(34), 1999, pp. 10989-10996

Authors: Kauffmann, HM Keppler, D Gant, TW Schrenk, D

Citation: Hm. Kauffmann et al., Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen, ARCH TOXIC, 72(12), 1998, pp. 763-768